KURT A GUSTAFSON

CIK 1462354 · Executive VP, Finance and CFO · last filed 2026-04-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$311.9K

Companies

5

Total Filings

85

Lifetime Open-Market Net

-$1.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OABIW Executive VP, Finance and CFO 261,483 $0.10 $26.1K -$376.2K 19 2026-04-07
XNCR Director 23,176 $12.33 $285.8K -$403.8K 15 2025-06-16
SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted EVP & Chief Financial Officer 345,417 $1.03 $355.8K -$1.12M 35 2022-03-16
Niagen Bioscience, Inc. (CDXC) Delisted Director $7.87 $0 6 2021-06-22
HALOZYME THERAPEUTICS, INC. (HTI) Delisted Vice President and CFO 31,709 $47.0K 8 2013-02-06

Recent Filings · Page 8 of 9

85 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-06-11 XNCR Grant (A) $0 EDGAR
2015-06-05 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Tax (F) −10,067 -$62.3K EDGAR
2015-02-20 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Mixed +22,128 -$20.8K EDGAR
2014-12-23 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) $0 EDGAR
2014-07-16 XNCR Grant (A) $0 EDGAR
2014-03-27 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +15,000 $0 EDGAR
2013-06-05 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +100,000 $0 EDGAR
2013-02-06 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Grant (A) $0 EDGAR
2013-02-05 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Exer (M) +12,467 $0 EDGAR
2012-05-17 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Exer (M) +15,200 $0 EDGAR
Showing 7180 of 85
Page 8 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.